Cargando…

Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss

BACKGROUND: Accruing evidence indicates that accumulation of advanced glycation end products (AGEs) and activation of the receptor for AGEs (RAGE) play a significant role in obesity and type 2 diabetes. The concentrations of circulating RAGE isoforms, such as soluble RAGE (sRAGE), cleaved RAGE (cRAG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popp, Collin J, Zhou, Boyan, Manigrasso, Michaele B, Li, Huilin, Curran, Margaret, Hu, Lu, St-Jules, David E, Alemán, José O, Vanegas, Sally M, Jay, Melanie, Bergman, Michael, Segal, Eran, Sevick, Mary A, Schmidt, Ann M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	ORIGINAL RESEARCH
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071542/ https://www.ncbi.nlm.nih.gov/pubmed/35542387 http://dx.doi.org/10.1093/cdn/nzac046

Ejemplares similares

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020)

Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease
por: Fuller, Kelly N. Z., et al.
Publicado: (2018)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM
por: Miranda, Edwin R., et al.
Publicado: (2019)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Biswas, Subrata K.
Publicado: (2019)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
por: Kim, Taehee, et al.
Publicado: (2023)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients
por: Jung, Eul Sik, et al.
Publicado: (2017)

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro
por: Miller, Suzanne, et al.
Publicado: (2016)

sRAGE in septic shock: a potential biomarker of mortality
por: Hamasaki, Mike Yoshio, et al.
Publicado: (2014)

DNA and sRAGE circulation in the early phase after polytrauma
por: Joly, P, et al.
Publicado: (2015)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
por: Erusalimsky, Jorge D.
Publicado: (2021)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021)

Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease
por: Liu, Wenjun, et al.
Publicado: (2022)

Letter to the Editor, Reacting to: “APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism”
por: Mooldijk, Sanne S, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Dietary Counseling Session Attendance and Self-Monitoring Adherence Dur034 a Behavioral Weight Loss Intervention
por: Mottern, Meredith, et al.
Publicado: (2022)

The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
por: Chen, Der-Yuan, et al.
Publicado: (2015)

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018)

Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study
por: Saputra, Gusti Noor Ramadany, et al.
Publicado: (2022)

sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells
por: Zhang, Fang, et al.
Publicado: (2017)

Retracted: Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Reply to Biswas: Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Pouwels, Simon D., et al.
Publicado: (2019)

The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients
por: Chiang, Kuang-Hsing, et al.
Publicado: (2018)

A Randomized Clinical Trial to Compare a Precision Nutrition Intervention Targeting a Reduction in Postprandial Glycemic Response to Meals With a Low-Fat Diet for Weight Loss
por: Popp, Collin, et al.
Publicado: (2022)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
por: Deo, Permal, et al.
Publicado: (2023)

Affimers as an Alternative to Antibodies in an Affinity LC–MS Assay for Quantification of the Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Human Serum
por: Klont, Frank, et al.
Publicado: (2018)

sRage plasma level in association with multiple sclerosis risk in Slovak population
por: Dobrota, Dusan, et al.
Publicado: (2015)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
por: Negrin, Lukas L., et al.
Publicado: (2019)

sRAGE and early signs of cardiac target organ damage in mild hypertensives
por: Maresca, Andrea Maria, et al.
Publicado: (2019)

Association between plasma sRAGE and emphysema according to the genotypes of AGER gene
por: Sin, Sooim, et al.
Publicado: (2022)

sRAGE alleviates SARS-CoV-2-induced pneumonia in hamster
por: Zhang, Xiuqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33qtoiotleptrckubf19fhi3fc